NemaLife Inc.
Grant Campany is currently the Chief Business Officer at AceLink Therapeutics, a world leader in developing advanced oral therapies for inherited disorders of glycolipid metabolism. Grant is also the Chief Financial Officer at NemaLife, Inc., a TechBio company focusing on humanized biological safety and efficacy testing of various substances. In the past, Grant has held leadership positions at Renovar Bio, Yinuoke Biopharma, XPRIZE, Microdermics, FDA, B LOGiQ Consultancy, Gordon and Betty Moore Foundation, and PPD Discovery. Grant has a Master of Business Administration (MBA) degree in Banking & Corporate Finance and a Bachelor of Science in Business (BSB) degree in Biology & Business Management from the University of Minnesota - Carlson School of Management.
This person is not in any offices
NemaLife Inc.
2 followers
NemaLife brings low-cost whole organism assays early into the product development cycle thereby de-risking business investments. We offer in vivo testing and screening services to a variety of industries and provide actionable data at the price and scale of in vitro assays.